Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to...
Civica Rx partners with Thermo Fisher Scientific to develop and manufacture drugs with a history of drug shortages
Civica Rx announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of...
GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma
The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for...
Aptar Pharma’s Nasal Unidose Device Again Approved by US FDA for New Nasal Seizure Rescue Treatment
Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, announced that its patented Unidose Liquid System is the device...
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22
Ascletis Pharma Inc announces the approval for ASC22 to conduct clinical trials in chronic hepatitis B patients in China from China's National Medical Products...
Grey Wolf Therapeutics completes £2.5 million Series A2 financing to accelerate development of therapies targeting ERAP2
Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), announces it has completed a £2.5 million ($3.3...
Fycompa for Adjunctive treatment of Partial Onset Seizures launched in China
Eisai Co., Ltd announced hat it has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa®, generic name perampanel) for use in adjunctive...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...